Cholinergic components of frontal lobe function and dysfunction. Neurochemistry of cognition: erotonergic and adrenergic mechanisms. Cortical neuroanatomy and cognition. Functional neuroimaging of cognition. Neuropsychology of aging and dementia. Neuropsychological testing: bedside approaches. Anterograde amnesia. Retrograde memory loss. Disorders of semantic memory. Implicit learning and memory. Working memory. The dysexecutive syndromes. Apraxia of speech. Aphasia. Cognitive processes underlying reading and writing and their neural substrates. Apraxia. Acalculia. Hemispatial neglect. Visuospatial and visuoconstructive deficits. Optic ataxia and Bálint’s syndrome: neuropsychological and neurophysiological prospects. Visual agnosia. Illusory perceptions of the human body and self. The musical brain. Visual art and the brain. Laboratory testing of emotion and frontal cortex. Neuropsychological characterization of mild cognitive impairment. Neuropsychology of Alzheimer’s disease. Neuropsychology of frontotemporal dementia. Neuropsychology of dementia with Lewy bodies. The neuropsychology of vascular dementia.
This volume is part of the Handbook of Clinical Neurology series, the world's most comprehensive source of information in neurology. Now in its third generation, the series has an unparalleled reputation for providing the latest foundational research, diagnosis, and treatment protocols essential for both basic neuroscience research and clinical neurology.
Dr. Miller holds the A.W. and Mary Margaret Clausen Distinguished
Professorship in Neurology at the University of California, San
Francisco (UCSF). He directs the busy UCSF dementia center where
patients in the San Francisco Bay Area and beyond receive
comprehensive clinical evaluations. His goal is the delivery of
model care to all of the patients who enter the clinical and
research programs at the UCSF Memory and Aging Center (MAC).
Dr. Miller is a behavioral neurologist focused on dementia with
special interests in brain and behavior relationships as well as
the genetic and molecular underpinnings of disease. His work in
frontotemporal dementia (FTD) emphasizes both the behavioral and
emotional deficits that characterize these patients, while
simultaneously noting the visual creativity that can emerge in the
setting of FTD. He is the principal investigator of the
NIH-sponsored Alzheimer’s Disease Research Center (ADRC) and
program project on FTD called Frontotemporal Dementia: Genes,
Imaging and Emotions. He oversees a healthy aging program, which
includes an artist in residence program. In addition, he helps lead
two philanthropy-funded research consortia, the Tau Consortium and
Consortium for Frontotemporal Research, focused on developing
treatments for tau and progranulin disorders, respectively. Also,
he works with the National Football League to help with the
education and assessment of players related to brain health. Dr.
Miller teaches extensively, runs the Behavioral Neurology
Fellowship at UCSF, and oversees visits of more than 50 foreign
scholars every year.
Dr. Miller has received many awards including the Potamkin Award
from the American Academy of Neurology, the Raymond Adams Lecture
at the American Neurological Association, the Elliot Royer Award
from the San Francisco Neurological community, the UCSF Annual
Faculty Research Lectureship in Clinical Science, the UCSF Academic
Senate Distinction in Mentoring Award, Distinguished Service to
Minorities, from Charles Drew University, and the Gene D. Cohen
Research Award in Creativity and Aging from the National Center for
Creative Aging. He has authored The Human Frontal Lobes, The
Behavioral Neurology of Dementia, Frontotemporal Dementia and over
600 other publications regarding dementia. He has been featured in
Fortune magazine and The New York Times, as well as on "Charlie
Rose," "PBS NewsHour" and other media. For more than three decades,
Dr. Miller has been the scientific director for the philanthropic
organization The John Douglas French Alzheimer’s Foundation, a
private philanthropic organization that funds basic science
research in Alzheimer’s disease.
Ask a Question About this Product More... |